Medicine ignored women’s bodies – now femtech is filling the gap | News

Tayla Kenyon thought she had “really bad depression, bad anxiety, personality disorders” before blaming her symptoms on her menstrual period.

She suffers from premenstrual dysphoric disorder (PMDD). It is a condition that affects approximately one in 20 people who experience menstruation and causes severe mood and anxiety symptoms.

“I’ve definitely struggled with periods since I was probably 11. I was physically sick from the pain,” Kenyon said. Independent.

Women’s health problems such as PMDD have long been neglected in medical research; but the new wave of FemTech innovations aims to change this.

UK-based Samphire Neuroscience has developed a headband that uses transcranial stimulation to help treat symptoms of PMDD, endometriosis and premenstrual syndrome (PMS).

FemTech companies are part of a growing industry predicted to be worth £75.5bn by 2030.